Maplight is a biopharmaceutical company developing novel therapeutics for patients with central nervous system (CNS) disorders, including Autism Spectrum Disorder, Parkinson’s Disease, and Schizophrenia.
MapLight Therapeutics Highlights:
Overview
- Website: maplightrx.com
- Headquarters: Palo Alto, California
- Employees: 82
- Founded: 2018
- Email: info@maplightrx.com
- Funding: $305.0M
- Revenue: $12.7M
- Valuation: n/a
Contacts
- Email: ***@maplightrx.com
Similar companies
Frequently Asked Questions related to MapLight Therapeutics
MapLight Therapeutics is located in Palo Alto, California.
Yes, MapLight Therapeutics is a Silicon Valley company.
MapLight Therapeutics total funding is 305.0M.
MapLight Therapeutics revenue is 12.7M.
MapLight Therapeutics’s number of employees is 82.
MapLight Therapeutics’s CEO name is Chris Kroeger.
MapLight Therapeutics was founded in 2018.
MapLight Therapeutics’s contact email is info@maplightrx.com.
